Cargando…
Shaping the tumor microenvironment with Modified Vaccinia Virus Ankara and TLR9 ligand
Our preclinical data demonstrate that an intravenous injection of Modified Vaccinia virus Ankara induces CD8(+) lymphocytes to infiltrate organs to control the growth of orthotopic renal carcinoma upon combination with a toll-like receptor 9 agonist. Such shaping of the tumor microenvironment could...
Autores principales: | Préville, Xavier, Rittner, Karola, Fend, Laetitia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4485804/ https://www.ncbi.nlm.nih.gov/pubmed/26155396 http://dx.doi.org/10.1080/2162402X.2014.1003013 |
Ejemplares similares
-
Intravenous injection of a modified vaccinia ankara virus induces intratumoral CD8+ lymphocyte infiltration favoring tumor control in an orthotopic tumor model upon combinatorial treatment with a TLR9 agonist
por: Fend, Laetitia, et al.
Publicado: (2014) -
Immunomodulation of the tumor microenvironment by Toll-like receptor-3 (TLR3) ligands
por: Chew, Valerie, et al.
Publicado: (2013) -
Oncolytic virotherapy with an armed vaccinia virus in an orthotopic model of renal carcinoma is associated with modification of the tumor microenvironment
por: Fend, Laetitia, et al.
Publicado: (2015) -
Dendritic cells matured in the presence of TLR ligands overcome the immunosuppressive functions of regulatory T cells
por: Berk, Erik, et al.
Publicado: (2014) -
TLR2 ligation protects effector T cells from regulatory T-cell mediated suppression and repolarizes T helper responses following MVA-based cancer immunotherapy
por: Amiset, Laurent, et al.
Publicado: (2012)